ALXN - AstraZeneca appoints Aradhana Sarin as new finance chief

AstraZeneca (AZN) has appointed Aradhana Sarin as an Executive Director and Chief Financial Officer, conditional upon closing of acquisition of Alexion Pharmaceuticals (ALXN), effective on the later of 1 August 2021 or the date of closing.Dr. Sarin is currently Executive Vice-President, Chief Financial Officer of Alexion and will succeed Marc Dunoyer who will step down as CFO to become Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca.As CEO, Alexion, Mr. Dunoyer will lead the Rare Disease Unit of AstraZeneca, and develop Alexion’s strategic direction.Mr. Dunoyer will also continue with his responsibility as Chairman, AstraZeneca Japan.Source

For further details see:

AstraZeneca appoints Aradhana Sarin as new finance chief